We are monitoring the impact of COVID-19 on Europe Life Science Analytics Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 11498
Share on
Share on

Europe Life Science Analytics Market Research Report – Segmented By Analytics Type, Component, Delivery Mode, Application, End-Users and Country (United Kingdom, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands and Rest of Europe) - Industry Size, Share, Trends and Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 11498
Pages: 100

Europe Life Science Analytics Market Size (2021 to 2026)

The size of the European life science analytics market is forecasted to be growing at a CAGR of 9.2% between 2021 to 2026.

Y-O-Y rise in the number of pharmaceutical companies, growing R&D activities, and increasing demand for personalized medicines are expected to boost the European Life science analytics market. The demand for innovative analytics in various applications is significantly growing, which is expected to promote the market's growth rate. The rising adoption of AI and big data among the healthcare sector, the growing requirement for advancing data standardization, and the rising adoption of analytical solutions in clinical trials and technological advancements are further expected to accelerate the market growth.

Analytics plays a crucial role in the development of healthcare, microbiology, and others. The growing number of life science applications in the pharmaceutical sector, especially in clinical trials, drug discovery, and risk management, is further expected to drive the market. Life science analytics aid in limiting healthcare costs, decreased hospitalization and reduces required testing. Growing investments by the key market participants on the R&D applications to better the analytical solutions is a plus to the market growth.

High investment support required to develop and implement life science analytics is one of the significant factors hampering the market's growth rate. The market participants may face challenges with the research and development and regulatory changes.

Impact of COVID-19 on the Europe Life Science Analytics Market:

The sudden outbreak of COVID 19 has impacted all sectors, including the healthcare industry. The present coronavirus has resulted in the number of patients visiting the healthcare services daily. The rising number of COVID-19 cases, the absence of healthcare providers, and better patient data management are expected to favor the European life sciences analytics market. Due to this, the teleconsultations number has also increased, and combining EHR with other healthcare IT solutions such as telemedicine and e-prescriptions, permitting healthcare providers to create an interconnected network to enable the use of healthcare information technology (HCIT) for the diagnosis and prescription of patient medicines.

This research report on the European life science analytics market has been segmented and sub-segmented based on the following categories.

By Analytics Type:

  • Descriptive Analytics
  • Predictive Analytics
  • Prescriptive Analytics

By Component:

  • Software
  • Services

By Delivery Mode:

  • On-demand
  • On-premises

By Application:

  • Clinical and Preclinical Trials
  • Research and Development
  • Regulatory Compliance
  • Sales and Marketing
  • Supply Chain Management
  • Pharmacovigilance

By End-User:

  • Pharmaceutical and Biotechnology Companies
  • Medical Device Companies
  • Biomedical Research Centers
  • Third-party Administrators (TPA)

By Country:

  • UK
  • France
  • Spain
  • Germany
  • Italy
  • Russia
  • Sweden
  • Denmark
  • Switzerland
  • Netherlands
  • Turkey
  • Czech Republic
  • Rest of Europe

Geographically, the European life sciences analytics market had accounted for a substantial market share in the global market in 2020 and is predicted to grow at a healthy rate during the forecast period.

In the European market, the German life science analytics market is expected to be a lucrative regional market during the forecast period. Social advancements such as census and technological advancements such as digitization are favoring the German market.

The rising adoption of IoT along with cloud computing is expected to support the life science analytics market. With the growing acceptance of technological advancements, the life science industry has reached new heights, which is a plus to the life science analytics market. The rising focus of key market participants is estimated to boost the market.

The life science analytics markets in the UK and France are projected to have notable growth during the forecast period.

KEY MARKET PLAYERS:

SAS Institute Inc., IBM Corporation, Oracle Corporation, Quintiles, Inc., Accenture, Cognizant, Wipro Limited, TAKE Solutions, MaxisIT, Inc., and SCIO Health Analytics are a few of the companies playing a leading role in the European life science analytics market.

  1. Introduction
    1. Market Definition
    2. Study Deliverables
    3. Base Currency, Base Year and Forecast Periods
    4. General Study Assumptions
  2. Research Methodology
    1. Introduction
    2. Research Phases
        1. Secondary Research
        2. Primary Research
        3. Econometric Modelling
        4. Expert Validation
    3. Analysis Design
    4. Study Timeline
  3. Overview
    1. Executive Summary
    2. Key Inferences
    3. New Developments
  4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
    1. Market Drivers
    2. Market Restraints
    3. Key Challenges
    4. Current Opportunities in the Market
  5. Market Segmentation
    1. By Analytics Type
      1. Descriptive Analytics
      2. Predictive Analytics
      3. Prescriptive Analytics
      4. Y-o-Y Growth Analysis, By Analytics Type
      5. Market Attractiveness Analysis, By Analytics Type
      6. Market Share Analysis, By Analytics Type
    2. By Component
      1. Software
      2. Services
      3. Y-o-Y Growth Analysis, By Component
      4. Market Attractiveness Analysis, By Component
      5. Market Share Analysis, By Component
    3. By Delivery Mode
      1.  On-demand
      2. On-Premises
      3. Y-o-Y Growth Analysis, By Delivery Mode
      4. Market Attractiveness Analysis, By Delivery Mode
      5. Market Share Analysis, By Delivery Mode
    4. By Application
      1. Clinical and Preclinical Trials
      2. Research and Development
      3. Regulatory Compliance
      4. Sales and Marketing
      5. Supply Chain Management
      6. Pharmacovigilance
      7. Y-o-Y Growth Analysis, By Application
      8. Market Attractiveness Analysis, By Application
      9. Market Share Analysis, By Application
    5. By End-User
      1. Pharmaceutical and Biotechnology Companies
      2. Medical Device Companies
      3. Biomedical Research Centers
      4. Third-party Administrators (TPA)
      5. Y-o-Y Growth Analysis, By End-User
      6. Market Attractiveness Analysis, By End-User
      7. Market Share Analysis, By End-User
  6. Geographical Analysis
    1. Europe
      1. Introduction
      2. UK
      3. France
      4. Spain
      5. Germany
      6. Italy
      7. Russia
      8. Sweden
      9. Denmark
      10. Switzerland
      11. Netherlands
      12. Turkey
      13. Czech Republic
      14. Rest of Europe
  7. Strategic Analysis
    1. PESTLE analysis
      1. Political
      2. Economic
      3. Social
      4. Technological
      5. Legal
      6. Environmental
    2. Porter’s Five analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Consumers
      3. Threat of New Entrants
      4. Threat of Substitute Products and Services
      5. Competitive Rivalry within the Industry
  8. Market Leaders' Analysis
    1. SAS Institute Inc.
      1. Overview
      2. Product Analysis
      3. Strategic Evaluation and Operations
      4. Financial analysis
      5. Legal issues
      6. Recent Developments
      7. SWOT analysis
      8. Analyst View
    2. IBM Corporation
    3. Oracle Corporation
    4. Quintiles, Inc
    5. Accenture
    6. Cognizant
    7. Wipro Limited
    8. TAKE Solutions
    9. MaxisIT, Inc.
    10. SCIO Health Analytics
  9. Competitive Landscape
    1. Market share analysis
    2. Merger and Acquisition Analysis
    3. Agreements, collaborations and Joint Ventures
    4. New Product Launches
  10. Market Outlook and Investment Opportunities
  11. Appendix
    1. List of Tables
    2. List of Figures  
  • Regional, and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped.
  • The segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail.
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics.
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographics, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis.
  • Study the microenvironment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development.
  • A comprehensive list of key market players along with with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment.
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies.
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions.
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market.
  1. Europe Life Science Analytics Market, By Analytics Type, From 2021 to 2026 (USD Million)
  2. Europe Descriptive Analytics Market, By Region, From 2021 to 2026 (USD Million)
  3. Europe Predictive Analytics Market, By Region, From 2021 to 2026 (USD Million)
  4. Europe Prescriptive Analytics Market, By Region, From 2021 to 2026 (USD Million)
  5. Europe Life Science Analytics Market, By Component, From 2021 to 2026 (USD Million)
  6. Europe Software Market, By Region, From 2021 to 2026 (USD Million)
  7. Europe Services Market, By Region, From 2021 to 2026 (USD Million)
  8. Europe Life Science Analytics Market, By Delivery Mode, From 2021 to 2026 (USD Million)
  9. Europe On-demand Market, By Region, From 2021 to 2026 (USD Million)
  10. Europe On-premises Market, By Region, From 2021 to 2026 (USD Million)
  11. Europe Life Science Analytics Market, By Application, From 2021 to 2026 (USD Million)
  12. Europe Clinical and Preclinical Trials Market, By Region, From 2021 to 2026 (USD Million)
  13. Europe Research and Development Market, By Region, From 2021 to 2026 (USD Million)
  14. Europe Regulatory Compliance Market, By Region, From 2021 to 2026 (USD Million)
  15. Europe Sales and Marketing Market, By Region, From 2021 to 2026 (USD Million)
  16. Europe Supply Chain Management Market, By Region, From 2021 to 2026 (USD Million)
  17. Europe Pharmacovigilance Market, By Region, From 2021 to 2026 (USD Million)
  18. Europe Life Science Analytics Market, By End-User, From 2021 to 2026 (USD Million)
  19. Europe Pharmaceutical and Biotechnology Companies Market, By Region, From 2021 to 2026 (USD Million)
  20. Europe Medical Device Companies Market, By Region, From 2021 to 2026 (USD Million)
  21. Europe Biomedical Research Centers Market, By Region, From 2021 to 2026 (USD Million)
  22. Europe Third-Party Administrators (TPA) Market, By Region, From 2021 to 2026 (USD Million)
  23. U.K. Life Science Analytics Market, By Analytics Type, From 2021 to 2026 (USD Million)
  24. U.K. Life Science Analytics Market, By Component, From 2021 to 2026 (USD Million)
  25. U.K. Life Science Analytics Market, By Delivery Mode, From 2021 to 2026 (USD Million)
  26. U.K. Life Science Analytics Market, By Application, From 2021 to 2026 (USD Million)
  27. U.K. Life Science Analytics Market, By End-User, From 2021 to 2026 (USD Million)
  28. Germany Life Science Analytics Market, By Analytics Type, From 2021 to 2026 (USD Million)
  29. Germany Life Science Analytics Market, By Component, From 2021 to 2026 (USD Million)
  30. Germany Life Science Analytics Market, By Delivery Mode, From 2021 to 2026 (USD Million)
  31. Germany Life Science Analytics Market, By Application, From 2021 to 2026 (USD Million)
  32. Germany Life Science Analytics Market, By End-User, From 2021 to 2026 (USD Million)
  33. France Life Science Analytics Market, By Analytics Type, From 2021 to 2026 (USD Million)
  34. France Life Science Analytics Market, By Component, From 2021 to 2026 (USD Million)
  35. France Life Science Analytics Market, By Delivery Mode, From 2021 to 2026 (USD Million)
  36. France Life Science Analytics Market, By Application, From 2021 to 2026 (USD Million)
  37. France Life Science Analytics Market, By End-User, From 2021 to 2026 (USD Million)
  38. Italy Life Science Analytics Market, By Analytics Type, From 2021 to 2026 (USD Million)
  39. Italy Life Science Analytics Market, By Component, From 2021 to 2026 (USD Million)
  40. Italy Life Science Analytics Market, By Delivery Mode, From 2021 to 2026 (USD Million)
  41. Italy Life Science Analytics Market, By Application, From 2021 to 2026 (USD Million)
  42. Italy Life Science Analytics Market, By End-User, From 2021 to 2026 (USD Million)
  43. Spain Life Science Analytics Market, By Analytics Type, From 2021 to 2026 (USD Million)
  44. Spain Life Science Analytics Market, By Component, From 2021 to 2026 (USD Million)
  45. Spain Life Science Analytics Market, By Delivery Mode, From 2021 to 2026 (USD Million)
  46. Spain Life Science Analytics Market, By Application, From 2021 to 2026 (USD Million)
  47. Spain Life Science Analytics Market, By End-User, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample